Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii
Mark D Adams1, Karrie Goglin, Neil Molyneaux
1Department of Genetics, Case Western Reserve University School of Medicine, Cleveland, OH 44106-4955, USA. mda13@case.edu
Journal of Bacteriology
|October 22, 2008
Summary
Multidrug resistance (MDR) in Acinetobacter baumannii is driven by acquiring specific resistance genes. Inactivation enzymes play a larger role than efflux pumps in MDR, with resistance islands contributing significantly.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- The emergence of multidrug resistance (MDR) in Acinetobacter baumannii is a significant global health concern.
- Understanding the genetic basis of MDR is crucial for developing effective treatment strategies.
Purpose of the Study:
- To investigate the genomic repertoire of resistance determinants in MDR Acinetobacter baumannii.
- To compare the genetic organization and origins of resistance mechanisms between MDR and drug-susceptible isolates.
Main Methods:
- Comparative genome sequencing of three MDR and three drug-susceptible Acinetobacter baumannii isolates.
- Analysis of resistance determinants, mobile genetic elements, and shared genes across isolates.
Main Results:
- The MDR phenotype is attributed to the acquisition of discrete resistance determinants distributed throughout the genome.
- Inactivation enzymes appear to be more significant contributors to resistance than drug efflux for certain antibiotic classes.
- A variable resistance island, containing mobile genetic elements, contributes significantly but not universally to MDR.
Conclusions:
- Acquisition of specific resistance genes explains the MDR phenotype in Acinetobacter baumannii.
- Genomic analysis reveals key differences in resistance mechanisms, highlighting the role of inactivation enzymes.
- Shared genes suggest adaptations for human-associated growth, potentially influencing virulence and persistence.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

